Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, M779, San Francisco, California 94143, USA.
J Neurosurg. 2013 Feb;118(2):337-44. doi: 10.3171/2012.10.JNS12119. Epub 2012 Dec 7.
Focal cortical dysplasia (FCD) represents a spectrum of developmental cortical abnormalities and is one of the most common causes of intractable epilepsy in children and young adults. Outcomes after surgery for FCD are highly variable, and prognosticators of seizure freedom are unclear. In a subset of FCDs, a transmantle sign is observed on imaging that focally spans the entire cerebral mantle from the ventricle to the cortical surface. The aim of this study was to characterize seizure control outcomes and prognostic significance of the transmantle sign in FCD epilepsy.
Fourteen patients with the transmantle sign underwent epilepsy surgery for medically refractory epilepsy. Thirteen patients underwent resective surgery and 1 underwent multiple subpial transections with vagus nerve stimulator placement. Patient demographics, MRI, electroencephalography, intraoperative electrocorticography (ECoG), and pathology were reviewed. The results of this series were compared with those of 114 previously reported patients with FCD without the transmantle sign.
All patients were found to have childhood seizure onset and concordant MRI and ECoG findings. The primary MRI findings associated with transmantle sign included gray-white junction blurring, appearance of cortical thickening, T2 or FLAIR abnormality, and bottom-of-the-sulcus dysplasia. The transmantle sign was usually a focal finding, typically confined to 1 or several gyri with well-circumscribed epileptic tissue. Correlation of the transmantle sign with FCD histopathological subtypes was highly variable. Patients who underwent complete resection of MRI and ECoG abnormalities (12 of 13 patients) became seizure free. When compared with 114 FCD patients without the transmantle sign, patients with the transmantle sign showed significantly improved seizure-free outcomes after complete resections (p = 0.04).
The presence of the transmantle sign in patients with medically refractory partial epilepsy is associated with highly favorable seizure control outcomes after surgical treatment.
局灶性皮质发育不良(FCD)代表了一系列皮质发育异常,是儿童和年轻成人难治性癫痫的最常见原因之一。FCD 手术后的结果差异很大,且尚无明确的无癫痫发作预测因子。在 FCD 的亚组中,影像学上观察到跨脑膜征,该征象从脑室到皮质表面呈局灶性跨越整个大脑脑膜。本研究旨在描述 FCD 癫痫患者跨脑膜征的癫痫控制结果和预后意义。
14 例跨脑膜征患者因药物难治性癫痫接受癫痫手术。13 例患者接受了切除术,1 例接受了多发性软膜下横切术和迷走神经刺激器植入术。回顾患者的人口统计学、MRI、脑电图、术中皮层脑电图(ECoG)和病理。将本系列结果与 114 例先前报道的无跨脑膜征 FCD 患者的结果进行比较。
所有患者均发现存在儿童期起病、MRI 和 ECoG 表现一致。与跨脑膜征相关的主要 MRI 发现包括灰白质交界模糊、皮质增厚表现、T2 或 FLAIR 异常以及底沟发育不良。跨脑膜征通常为局灶性表现,通常局限于 1 个或几个脑回,具有边界清楚的癫痫组织。跨脑膜征与 FCD 组织病理学亚型的相关性差异很大。13 例患者中,12 例完成了 MRI 和 ECoG 异常的完全切除,这些患者无癫痫发作。与 114 例无跨脑膜征的 FCD 患者相比,跨脑膜征患者在完成完全切除后癫痫无发作的结果显著改善(p=0.04)。
药物难治性部分性癫痫患者存在跨脑膜征与手术治疗后高度良好的癫痫控制结果相关。